Cosmo is responsible for strategy and business development, primarily matching unique business opportunities to the scientific advantages of the partnership. He is responsible for some of the industry’s more creative translational research and commercialization models aimed at curing complex disease—freeing the most ambitious science entrepreneurs and ideas through unique capital creation.
Cosmo is involved at the early stages, working with institutes and scientists to design their vision based on unique intellectual property, helping growth-oriented companies achieve their next levels of success or helping larger entities utilize their existing infrastructure to capture new markets.
He was the Founder and CEO of United Advisors, a leading merchant bank focused on growth strategies and M&A. While at UA, he led the buildout of one of the fastest growing investment companies in the US, eventually listing on the NYSE.
Cosmo started his career with JP Morgan and received his MBA from the University of Connecticut.